| scholarly article | Q13442814 |
| P2093 | author name string | Richard Charboneau | |
| Roderick A Barke | |||
| Sabita Roy | |||
| Subhas Das | |||
| Jennifer Kelschenbach | |||
| P2860 | cites work | ERK dimers and scaffold proteins: unexpected partners for a forgotten (cytoplasmic) task. | Q50335945 |
| Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes | Q61774073 | ||
| Stress- and morphine-induced elevations of plasma and tissue cholesterol in mice: reversal by naltrexone | Q67947042 | ||
| Quantitative properties of plasma corticosterone elevation induced by naloxone-precipitated withdrawal in morphine-dependent rats | Q72576794 | ||
| Characterization of an activation protein-1-binding site in the murine interleukin-12 p40 promoter. Demonstration of novel functional elements by a reductionist approach | Q73694416 | ||
| Cross talk between nitric oxide and ERK1/2 signaling pathway in the spinal cord mediates naloxone-precipitated withdrawal in morphine-dependent rats | Q83377972 | ||
| Regulation of interleukin 12 p40 expression through an NF-kappa B half-site | Q24651221 | ||
| The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells | Q24678409 | ||
| Differential regulation of macrophage CCAAT-enhancer binding protein isoforms by lipopolysaccharide and cytokines | Q30919473 | ||
| Cytokine patterns in the pathogenesis of human leishmaniasis | Q33895266 | ||
| Interleukin 12 at the site of disease in tuberculosis | Q34140928 | ||
| Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12. | Q34194770 | ||
| Triptolide inhibits IL-12/IL-23 expression in APCs via CCAAT/enhancer-binding protein alpha | Q34245882 | ||
| Non-genomic effects of glucocorticoids in the neural system. Evidence, mechanisms and implications | Q34349834 | ||
| Stress-induced immunomodulation and the implications for health | Q34506497 | ||
| Stress and relapse to drug seeking: studies in laboratory animals shed light on mechanisms and sources of long-term vulnerability | Q35080432 | ||
| Making a bad thing worse: adverse effects of stress on drug addiction | Q36407029 | ||
| Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins | Q36570254 | ||
| Modulation of immune function by morphine: implications for susceptibility to infection | Q37015395 | ||
| Effects of opioid tolerance and withdrawal on the immune system | Q37015416 | ||
| The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. | Q37022008 | ||
| Opioid-induced immunosuppression | Q37237103 | ||
| Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal | Q37244714 | ||
| Activation of the spinal ERK signaling pathway contributes naloxone-precipitated withdrawal in morphine-dependent rats | Q38318756 | ||
| Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors | Q38346654 | ||
| Disparate regulation of LPS-induced MAPK signaling and IL-12p40 expression between different myeloid cell types with and without HIV infection. | Q39745489 | ||
| Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteins | Q39900720 | ||
| Cyclosporin A and FK506 inhibit IL-12p40 production through the calmodulin/calmodulin-dependent protein kinase-activated phosphoinositide 3-kinase in lipopolysaccharide-stimulated human monocytic cells | Q40161639 | ||
| Cytokine patterns at the site of mycobacterial infection | Q40505087 | ||
| Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. | Q41118171 | ||
| Effects of morphine and morphine withdrawal on brainstem neurons innervating hypothalamic nuclei that control the pituitary-adrenocortical axis in rats | Q43032736 | ||
| Role of hypothalamic-pituitary axis in morphine-induced alteration in thymic cell distribution using mu-opioid receptor knockout mice | Q43662399 | ||
| Abrupt or precipitated withdrawal from morphine induces immunosuppression | Q44014891 | ||
| Effect of naloxone-precipitated morphine withdrawal on CRH and vasopressin mRNA expression in the rat hypothalamic paraventricular nucleus | Q44216438 | ||
| Assessment of endogenous opioid mediation in stress-induced hypercholesterolemia in the rat. | Q44343758 | ||
| Withdrawal from morphine in mice suppresses splenic macrophage function, cytokine production, and costimulatory molecules | Q44641628 | ||
| Paradoxes of immunosuppression in mouse models of withdrawal | Q44740871 | ||
| Morphine withdrawal sensitizes mice to lipopolysaccharide: elevated TNF-alpha and nitric oxide with decreased IL-12. | Q46507475 | ||
| Morphine withdrawal contributes to Th cell differentiation by biasing cells toward the Th2 lineage | Q46635985 | ||
| Splenic macrophages and B cells mediate immunosuppression following abrupt withdrawal from morphine | Q46735687 | ||
| Effects of morphine tolerance and abstinence on cellular immune function | Q48140969 | ||
| Morphine Tolerance, Physical Dependence, and Synthesis of Brain 5-Hydroxytryptamine | Q49118851 | ||
| P433 | issue | 34 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipopolysaccharide | Q421804 |
| morphine | Q81225 | ||
| P1104 | number of pages | 12 | |
| P304 | page(s) | 29806-29817 | |
| P577 | publication date | 2011-07-05 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Morphine withdrawal stress modulates lipopolysaccharide-induced interleukin 12 p40 (IL-12p40) expression by activating extracellular signal-regulated kinase 1/2, which is further potentiated by glucocorticoids | |
| P478 | volume | 286 |
| Q53637503 | A protease-activated receptor 2 agonist (AC-264613) suppresses interferon regulatory factor 5 and decreases interleukin-12p40 production by lipopolysaccharide-stimulated macrophages: Role of p53. |
| Q37227396 | CCL5 and cytokine expression in the rat brain: differential modulation by chronic morphine and morphine withdrawal |
| Q48904364 | Foxo3a transcriptionally upregulates AQP4 and induces cerebral edema following traumatic brain injury |
| Q40432327 | Gut Homeostasis, Microbial Dysbiosis, and Opioids |
| Q35952061 | Morphine decreases bacterial phagocytosis by inhibiting actin polymerization through cAMP-, Rac-1-, and p38 MAPK-dependent mechanisms |
| Q55373987 | Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model. |
| Q36694953 | Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections |
| Q90378265 | Temporal and Site-Specific Changes in Central Neuroimmune Factors During Rapid Weight Gain After Ovariectomy in Rats |
| Q35977809 | The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice |
| Q89555422 | The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females |
| Q36703869 | Β-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes |
Search more.